Skip to main content
Top navigation
  • Sustainability reports
  • Focus area: Increase resource efficiency
  • Governance
  • Please fill out this field

Main navigation

    • Our offering
        • Solids & others
            • Manufacturing
                • Solids
                • Semi-solids
                • Liquids
                • Pharmaceutical packaging
                • Controlled drugs
                • High Potent
        • Sterile delivery
            • Manufacturing
                • Sterile vial filling
                • PFS and cartridges
                • Lyophilisation
                • Blow-fill-seal
                • Ampoules
            • Specialised services
                • Ophthalmics
                • Beta-lactams
                • Vaccine manufacturing
        • Advanced Bio
            • Modalities & services
                • xRNA therapies
                • Virus & viral vectros
                • Microbial & live biotherapeutic products
                • Recombinant proteins
            • Continuous manufacturing
            • Innovations & collaborations
        • Additional services
            • ReciPredict
            • Analytical services
            • Regulatory
            • New product introduction
                • Technology Transfer
                • Product development
    • Resources
    • About us
        • About us
            • Our leadership
            • Why partner with us
            • Locations
        • Sustainability
            • Sustainability reports
            • Sustainability strategy
            • Net Zero commitment
            • Governance
        • News & Events
            • Press releases
            • Events
    • Careers
        • Careers
            • Who we are
            • Working with us
            • What you can do
            • Job search
    • Contact
Linkedin
Contact
Please fill out this field
No banner Image

Press releases

  • Home
  • About us
  • Press releases
  • Facebook
  • Linkedin
  • Twitter
  • Email

BU-NOT-SET

CONTACT US
March 09 2023
Recipharm's Arranta Bio expands RNA process development capacity by 50 per cent to meet increased customer demand
December 05 2022
Recipharm announces extension of commercial manufacturing to support RedHill Biopharma's Talicia® to 2026
October 25 2022
Recipharm bolsters blow-fill-seal capabilities with Lab+
October 19 2022
Recipharm strengthens pre-filled syringe and cartridge offering with new investment
September 29 2022
Transpire Bio announces second agreement with Recipharm for the development of two additional inhaled medicines
April 11 2022
Recipharm completes US biologics acquisitions
March 10 2022
Recipharm pledges support to conflict victims
February 23 2022
Recipharm invests in new high-speed filling line to meet demand for aseptic products
February 18 2022
Recipharm expands its advanced therapy medicinal products (ATMPs) offering into Virotherapies with the acquisition of Vibalogics
February 18 2022
Recipharm acquires Arranta Bio, a CDMO leader in advanced therapy medicinal products (ATMPs), to expand its biologics offering in the US

Pagination

  • First page
  • Previous page
  • …
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Next page
  • Last page

Footer Webfrom

contact form

Let’s discuss your 
next project

Share your details and start your journey with our global CDMO team.

Stay updated
https://se.linkedin.com/company/recipharm https://www.youtube.com/channel/UCr-bw7pCCkYZfeImOwTfNRg
Footer
  • Privacy policy
  • Cookies
  • Website terms
  • Sitemap
  • Cookie settings
  • Terms & conditions
  • Code of Conduct
© 2025

Recipharm AB. All rights reserved. RECIPHARM® is a registered trademark owned by Recipharm AB.

Delivered by Investisdigital [iDX]